Compare IDEXX Laboratories, Inc. (IDXX) vs Kraft Heinz Co (KHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Kraft Heinz Co — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Kraft Heinz Co trades at $22.27 (market cap $26.66B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and Kraft Heinz Co pays a 7.12% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Kraft Heinz Co for 129 Days on average.
| IDXX | KHC | |
|---|---|---|
Market Cap | $40.43B | $26.66B |
Volume | 692,164 | 31,300,109 |
Sector | Health | Consumer Staples |
52-Week High | $766.68 | $27.62 |
52-Week Low | $504.70 | $21.21 |
Typical Hold Time | 46 Days | 129 Days |
Enterprise Value | $41.32B | $42.98B |
Dividend Yield | — | 7.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
Kraft Heinz (KHC) trades at $22.27, up 1.32% today, with a bearish technical signal but positive earnings beats in recent quarters. The company faces fundamental headwinds, including a net loss of $5.85 billion in 2025 and a negative net income margin of -13.64%, though operating cash flow remains strong at $4.46 billion. Recent news highlights turnaround efforts, such as new product launches and a $700 million reinvestment plan, amid a high dividend yield and mixed analyst sentiment.
The outlook is cautious due to profitability challenges and high debt, but the stock's low valuation (P/E of 13.04, P/B of 0.74) and consistent cash flow offer potential for value investors. Risks include sustained volume declines and competitive pressures, while the consensus price target of $24.50 suggests modest upside if turnaround initiatives gain traction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →
